Unusual Whales

17 posts published

AUG 23, 2021: FDA Grants Full Approval to Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine; (PFE) Acquires Trillium Therapeutics (TRIL) for $2.26 Billion

AUG 23, 2021: FDA Grants Full Approval to Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine; (PFE) Acquires Trillium Therapeutics (TRIL) for $2.26 Billion

Pfizer (PFE) and BioNTech (BNTX) topped headlines this morning when the FDA announced its full approval of the two companies’ mRNA-based COVID-19 vaccination. The vaccination, marketed under the name “COMIRNATY” is the first COVID-19 vaccination to receive full FDA approval in the United States, potentially marking a path forward for

AUG 20, 2021: Macy’s (M) Receives Numerous Price Upgrades, Spotify (SPOT) Announces $1b Share Repurchase Program, Marin (MRIN) and Wabash National (WNC) Announce Buybacks

AUG 20, 2021: Macy’s (M) Receives Numerous Price Upgrades, Spotify (SPOT) Announces $1b Share Repurchase Program, Marin (MRIN) and Wabash National (WNC) Announce Buybacks

Yesterday (Thursday, August 19), we posted an article discussing Macy’s ($M) stellar earnings report, and their revitalization of nationally beloved Toys ‘R Us. Since then, Macy’s has seen number of price target (PT) upgrades from analysts. The image below (taken from the Unusual Whales Live News Flow tool)

AUG 19, 2021: Macy’s in the Limelight; Blow-Out Quarter 2 Report, Reinstating Dividends, Brings beloved Toys R’ Us Back to Life! Options Flow Reflects Bullish Sentiment

(M) Macy’s blew analyst expectations out of the water this morning in theirQuarter 2 Earnings Reportreleased before market hours. With an adjusted Earnings per Share (EPS) of $1.29 for the second quarter, over 600% higher than the $0.19 EPS expected by market analysts. Macy’s also displayed